Stem cells for heart disease? First things first

The linkurl:Keystone Symposium;http://www.the-scientist.com/blog/display/23134/ I?m at this week in Santa Fe is billed as being about two related subjects: the molecular mechanisms of cardiac disease and the molecular mechanisms of regeneration. And while the talks on regeneration ? that translates here roughly into stem cell therapy ? are mostly scheduled for today (Wednesday) and tomorrow, the use of stem cells to regenerate the heart is already the loud buzz at poster sessions, and is at leas

Ivan Oransky
Feb 21, 2006
The linkurl:Keystone Symposium;http://www.the-scientist.com/blog/display/23134/ I?m at this week in Santa Fe is billed as being about two related subjects: the molecular mechanisms of cardiac disease and the molecular mechanisms of regeneration. And while the talks on regeneration ? that translates here roughly into stem cell therapy ? are mostly scheduled for today (Wednesday) and tomorrow, the use of stem cells to regenerate the heart is already the loud buzz at poster sessions, and is at least a whisper in talks whose subjects suggest they about pure molecular mechanisms. Take, for example, linkurl:Randall Moon,;http://www.hhmi.org/research/investigators/moon_bio.html who opened the meeting with a discussion of the role of the Wnt/beta catenin signaling pathway in zebrafish tail fin regeneration. Before you knew it, Moon had jumped very quickly to the suggestion that such a pathway might be a target for improving cardiac regeneration strategies using progenitor cells. He backed that idea with he called ?science fair...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?